ATXN3 and Huntington disease: The implementation of preventive diagnostics has demonstrated efficacy in the management of various polyglutamine diseases, including Huntington’s disease in Mexico [27,28,29,30] and SCA2 and SCA3 in Cuba and Brazil, respectively [31,32,33,34,35].